|
|
|
"It was recently reported that administration of the metabotropic glutamate 2 and 3 (mGlu2/3) receptor agonist prodrug LY2140023 to schizophrenic patients decreased positive symptoms. However, at the single, potentially...
The copper sequestering drug tetrathiomolybdate (TM) has been shown in studies to be effective in the treatment of Wilson disease, a disease caused by an overload of copper, and certain metastatic cancers. That much is known....
The Associated Press INSIDE WASHINGTON: Stream of WH health care visits The Associated Press WASHINGTON — President Barack Obama's top aides met frequently with lobbyists and health care industry heavyweights as his...
JANUVIA (jah-NEW-vee-ah) is a once-daily prescription pill that, along with diet and exercise, helps lower blood sugar levels in people with type 2 diabetes. Important Information About JANUVIA JANUVIA has not been studied with...
According to recent research published in the Journal of Allergy and Clinical Immunology, "Frequencies of behavior-related adverse experiences (BRAEs) in controlled clinical studies of leukotriene modifier drugs have not been...
According to recent research from the United States, "Compare healthcare utilization and total payments for community-acquired pneumonia (CAP) episodes-of-care among 5 health plan designs spanning the continuum of managed care....
Related topics: Mergers and acquisitions, Industry Drivers US drugmaker Merck & Co is to close a New Jersey warehouse owned by recent acquisition Schering-Plough, cutting 80 jobs. The facility, in Hunterdon County, stores and...
Regulatory News: The Swedish biotech company Karo Bio (Reuters: KARO.ST) today announced that Merck & Co., Inc., through an affiliate, plans to enter a clinical phase IIa trial with the collaboration's lead investigational drug...
Merck Serono S APosted on:25 Nov 09 Merck Serono Launches New Website on PhenylketonuriaPR NewswireGENEVA, November 25 GENEVA, November 25 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany,...
Science|Business reporting Merck Serono has announced it is to establish a global R&D centre in Beijing, China, investing more than €150 million and creating 200 new jobs over the next four years. The centre will specialise in...
